← All organizations

Ayala Pharmaceuticals, Inc,

Ayala Pharmaceuticals, Inc,

For profitWebsite ↗

Also known as: Ayala Pharmaceuticals, Inc,

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Mar 30, 2021

Timeline

2010s

Jul 1, 2017
Ayala Pharmaceuticals, Inc,— Founded

2020s

Jan 3, 2023
Advaxis, Inc.— Acquired
Jul 27, 2023
BioSight Ltd.— Acquired

Drugs by trial phase (15 distinct, 20 trials)

Phase 3 (1 own, 1 via acquisition)

Phase 2 (2 own, 10 via acquisition)

Phase 1 (0 own, 1 via acquisition)

adxs-neo

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (3)

NCT04871282Lead sponsorPhase 2/Phase 3Mar 30, 2021
NCT04461600Lead sponsorPhase 2Aug 14, 2020
NCT03691207Lead sponsorPhase 2Oct 31, 2018

Details

Founded: Rehovot, IL Jul 1, 2017
Last known activity: Mar 30, 2021